Monopar Therapeutics (MNPR) EPS (Basic) (2017 - 2025)
Monopar Therapeutics' (MNPR) quarterly EPS (Basic) came in at -$0.48 in Q3 2025, down 29.73% year-on-year from -$0.68 in Q3 2024, and down 37.14% quarter-over-quarter from -$0.35 in Q2 2025.
Monopar Therapeutics (MNPR) EPS (Basic) (2017 - 2025) Analysis & Trends
Monopar Therapeutics has disclosed EPS (Basic) across 9 years of filings, most recently posting -$0.48 for Q3 2025.
- EPS (Basic) for Q3 2025 came in at -$0.48, down 29.73% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.21 (up 11.68% YoY), and the FY2024 annual result was -$4.11, down 35.64% from the prior year.
- EPS (Basic) came in at -$0.48 for Q3 2025 at Monopar Therapeutics, down from -$0.35 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.16 in Q1 2021 to a low of -$1.1 in Q4 2022.
- The 5-year median for EPS (Basic) is -$0.22 (2022), against an average of -$0.36.
- Across the five-year window, EPS (Basic) sank 426.08% in 2022 and soared 46.38% in 2024, its largest moves.
- Monopar Therapeutics' EPS (Basic) stood at -$0.21 in 2021, then tumbled by 426.08% to -$1.1 in 2022, then surged by 37.54% to -$0.69 in 2023, then jumped by 46.38% to -$0.37 in 2024, then fell by 29.73% to -$0.48 in 2025.
- The last three EPS (Basic) figures came in at -$0.48 (Q3 2025), -$0.35 (Q2 2025), and -$0.38 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.06 |
| 10 | Monopar Therapeutics | 441.25 Mn | 441.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.48 |
| Jun 30, 2025 | -0.35 |
| Mar 31, 2025 | -0.38 |
| Sep 30, 2024 | -0.37 |
| Jun 30, 2024 | -0.49 |
| Mar 31, 2024 | -0.51 |
| Sep 30, 2023 | -0.69 |
| Jun 30, 2023 | -0.16 |
| Mar 31, 2023 | -0.19 |
| Dec 31, 2022 | -1.10 |
| Sep 30, 2022 | -0.19 |
| Jun 30, 2022 | -0.22 |
| Mar 31, 2022 | -0.19 |
| Dec 31, 2021 | -0.21 |
| Sep 30, 2021 | -0.20 |
| Jun 30, 2021 | -0.17 |
| Mar 31, 2021 | -0.16 |
| Dec 31, 2020 | -0.19 |
| Sep 30, 2020 | -0.15 |
| Jun 30, 2020 | -0.14 |